J1575 HCPCS Level II code: Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
J1575 is the HCPCS code for “Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
Short description: Hyqvia 100mg immuneglobulin
HCPCS · United States
Medicare details
The indicators CMS publishes with J1575 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2016
Where J1575 sits
- 1J codesDrugs administered other than orally
- 2Active code J1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1575 mean?
J1575 is the HCPCS code for “Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1575?
CMS lists J1575’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1575
All J codesJ1569Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mgJ1570Injection, ganciclovir sodium, 500 mgJ1571Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 mlJ1572Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mgJ1573Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 mlJ1574Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mgJ1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mgJ1577Injection, immune globulin (qivigy), 100 mgJ1580Injection, garamycin, gentamicin, up to 80 mgJ1590Injection, gatifloxacin, 10 mgJ1595Injection, glatiramer acetate, 20 mgJ1596Injection, glycopyrrolate, 0.1 mg